World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA – A CASE REPORT

*Prakas K Mandal, Pamela Nayek and Tuphan Kanti Dolai.

ABSTRACT

Posterior Reversible Encephalopathy Syndrome is a clinic-radiological entity presenting with headache, seizures, visual alterations etc. with transient lesions on neuroimaging. There are various conditions like toxaemia in pregnancy, toxic agents, post-transplantation, infections, autoimmune diseases etc. which can cause this syndrome. Here we present case report of a 10 years old child suffering from acute lymphoblastic leukemia who developed posterior reversible encephalopathy syndrome after methotrexate therapy. Prompt diagnosis of posterior reversible encephalopathy syndrome is utmost important to avoid delay in therapy and complications.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR